ArticleInternational journal of clinical oncology2025

Phase 1 study evaluating safety and pharmacokinetics of tusamitamab ravtansine monotherapy in Japanese patients with advanced malignant solid tumors.

Kei Muro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.